Supply Huperzine-A?1% CAS:102518-79-6

  • CasNo102518-79-6
  • Molecular FormulaC15H18N2O
  • Purity99.5%
  • AppearanceWhite Powder

Product Details

Quick Details

  • CasNo: 102518-79-6
  • Molecular Formula: C15H18N2O
  • Appearance: White Powder
  • Delivery Time: 3days after we receive the payment
  • Throughput: 1000|Kilogram|Month
  • Purity: 99.5%

Supply High Quality Huperzine-A 1% CAS:102518-79-6

1. Product Name:  Huperzine-A 1%

2. Specification: 1%

3. Appearance: White powder

4. Grade: Medicine Grade

5. Test Method: HPLC

6. Other Name: OTHER NAMES(S): HupA, Huperzina A, Huperzine, Huperzine-A, Selagine, Sélagine.

Huperzine A is a chemical extracted from Chinese club moss or fir club moss plants. It can also be made in a laboratory. Be careful not to confuse huperzine A, which is also called selagine, with similar sounding medications such as selegiline (Eldepryl). Also be careful not to confuse one of the brand names for huperzine A (Cerebra) with the brand names for unrelated prescription drugs such as celecoxib (Celebrex) and citalopram (Celexa). Huperzine A is used to improve memory and mental function in people with Alzheimer disease or other types of dementia.


How does it work

Huperzine A increases levels of a chemical called acetylcholine. This seems to help in diseases that interfere with memory and thinking (dementia), and in the muscle disease, myasthenia gravis.

Certificate of Analysis

Items Standard Results
Assay by HPLC: 1% 1.2%
Appearance: White fine powder Complies
Odor & taste: Slight bitter Complies
Mesh size: 100% pass 80mesh Complies
Solubility: Soluble in water Complies
Loss on drying: ≤2.0% 1.15%
Heavy metals PPM: <30ppm Complies


Total Plate Count:

Yeast & Mold:


S. Aureus:














Conclusion: Conform with USP35 standard

Possibly Effective for

  • Alzheimer disease. Taking huperzine A by mouth for up to 6 months may improve memory, thinking skills, and behavior in people with Alzheimer disease.

Insufficient Evidence for

  • Cocaine use disorder. Early research in a small number of people shows that taking huperzine A by mouth might reduce some of the effects of cocaine.
  • Depression. Early research shows that taking huperzine A by mouth does not reduce feelings of sadness in people with depression.
  • Memory. Some research shows that taking huperzine A by mouth for 4 weeks improves memory in healthy adolescents who complain of memory problems.
  • An autoimmune disorder that causes muscle weakness and muscle fatigue (myasthenia gravis). Early research shows that giving huperzine A as an injection into the muscle for 10 days may prevent muscle weakness in people with myasthenia gravis.
  • Schizophrenia. Taking huperzine A by mouth in addition to conventional medications might improve memory and some symptoms of schizophrenia.
  • Dementia caused by reduced blood flow to the brain (vascular dementia). Taking huperzine A by mouth may improve thinking skills in people with this condition.
  • Decline in memory and thinking skills in older people that is more than what is normal for their age.
  • Mental alertness.
  • Protection from nerve gases and other nerve poisons.
  • Other conditions.

More evidence is needed to rate the effectiveness of huperzine A for these uses.


Side Effects

When taken by mouth: Huperzine A is POSSIBLY SAFE for adults when taken for less than 6 months. It can cause some side effects including nausea, diarrhea, vomiting, dry mouth, constipation, sweating, blurred vision, slurred speech, fainting, restlessness, loss of appetite, cramping, inability to control urination, high blood pressure, dizziness, inability to sleep, and slowed heart rate.



The following doses have been studied in scientific research:


  • For Alzheimer disease: The most commonly used doses are 300-500 mcg daily.

Our Services